| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |